Atlas Trials

Expanded Access Program of AMTAGVI That is Out of Specification for Commercial Release

Clinical trial NCT05398640 · AVAILABLE

Trial details

NCT number
NCT05398640
Sponsor
Iovance Biotherapeutics, Inc.
Status
AVAILABLE
Study type
EXPANDED_ACCESS
Unresectable MelanomaMetastatic Melanoma

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.